Received May 5, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5S723-5 | — |
Penmenvy liquid portion only administration; Penmenvy liquid portion only administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 17-year-old female patient who received Men ABCWY NVS (Penmenvy) (batch number 5S723-5, expiry date 30-MAR-2028) for prophylaxis. On 24-APR-2026, the patient received Penmenvy. On 24-APR-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: Penmenvy liquid portion only administration) and inappropriate dose of vaccine administered (Verbatim: Penmenvy liquid portion only administration). This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.